Patents Assigned to Peptide Door Co., Ltd
  • Publication number: 20110098214
    Abstract: A lipopolysaccharide (LPS) and/or lipid A binding agent is provided. The LPS and/or lipid A binding agent contains an LPS and/or lipid A binding peptide, such as a peptide comprising an amino acid sequence of XYSSS (X=K, R, or H), or a derivative thereof, as an active ingredient. The LPS and/or lipid A binding agent is useful as, for example, an LPS and/or lipid A neutralizing agent or an LPS and/or lipid A removing agent.
    Type: Application
    Filed: December 3, 2010
    Publication date: April 28, 2011
    Applicant: PEPTIDE DOOR CO., LTD.
    Inventors: MEGUMI MATSUMOTO, MASATSUGU SUZUKI
  • Publication number: 20090048178
    Abstract: A lipopolysaccharide (LPS) and/or lipid A binding agent is provided. The LPS and/or lipid A binding agent contains an LPS and/or lipid A binding peptide, such as a peptide comprising an amino acid sequence of XYSSS (X=K, R, or H), or a derivative thereof, as an active ingredient. The LPS and/or lipid A binding agent is useful as, for example, an LPS and/or lipid A neutralizing agent or an LPS and/or lipid A removing agent.
    Type: Application
    Filed: November 22, 2006
    Publication date: February 19, 2009
    Applicant: Peptide Door Co., LTD.
    Inventors: Megumi Matsumoto, Masatsugu Suzuki
  • Publication number: 20060247424
    Abstract: The present invention provides: an anti-idiotype antibody which can be conveniently and economically produced compared with the existing type; a method of producing the anti-idiotype antibody; and a method of preparing a target idiotype antibody using the anti-idiotype antibody. A substance capable of binding to an antigen-binding site of a first antibody is prepared and this substance is ligated to a second antigen to give a fused antigen. Next, this fused antigen is bonded to a second antibody capable of binding to the second antigen, thereby giving an anti-idiotype antibody against the first antibody. In a method of preparing the idiotype antibody including: inoculating an animal with an anti-idiotype antibody against a specific idiotype antibody; and then further inoculating the animal with an antigen of the above idiotype antibody, the anti-idiotype antibody of the present invention is employed. Thus, the target idiotype antibody can be efficiently obtained.
    Type: Application
    Filed: August 22, 2003
    Publication date: November 2, 2006
    Applicant: Peptide Door Co., Ltd
    Inventor: Masatsugu Suzuki